These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23543036)

  • 21. Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.
    Rigamonti A; Lauria G; Grimod G; Bianchi G; Salmaggi A
    J Clin Neurosci; 2014 Apr; 21(4):690-1. PubMed ID: 24119342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor VII deficiency associated with valproate treatment.
    Unalp A; Dirik E; Kurul S
    Pediatr Int; 2008 Jun; 50(3):403-5. PubMed ID: 18533961
    [No Abstract]   [Full Text] [Related]  

  • 23. Valproate-related erythrodermia with reversible encephalopathy: a rare but serious adverse reaction, case report.
    Rener-Primec Z; Balkovec V
    Acta Dermatovenerol Alp Pannonica Adriat; 2014; 23(2):35-8. PubMed ID: 24964948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valproate-induced hyperammonemia as a cause of altered mental status.
    Feil D; Chuang K; Sultzer DL
    Am J Geriatr Psychiatry; 2002; 10(4):476-8. PubMed ID: 12095907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probable valproate sodium-associated hypotension.
    Ota KS
    Am J Geriatr Pharmacother; 2010 Jun; 8(3):281-4. PubMed ID: 20624617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Idiosyncratic adverse reactions to antiepileptic drugs.
    Zaccara G; Franciotta D; Perucca E
    Epilepsia; 2007 Jul; 48(7):1223-44. PubMed ID: 17386054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathological laughter following intravenous sodium valproate.
    Jacob PC; Chand RP
    Can J Neurol Sci; 1998 Aug; 25(3):252-3. PubMed ID: 9706729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fanconi syndrome caused by sodium valproate: report of three severely disabled children.
    Yoshikawa H; Watanabe T; Abe T
    Eur J Paediatr Neurol; 2002; 6(3):165-7. PubMed ID: 12363104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebellar atrophy in a child with valproate toxicity.
    Ghosh VB; Kapoor S; Prakash A; Bhatt S
    Indian J Pediatr; 2011 Aug; 78(8):999-1001. PubMed ID: 21243535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valproate-induced panhypogammaglobulinemia.
    Eom TH; Lee HS; Jang PS; Kim YH
    Neurol Sci; 2013 Jun; 34(6):1003-4. PubMed ID: 22797722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valproate-induced pseudoatrophy: expanding the clinical and imaging spectrum.
    Lovett M; Skidmore DL; Mohamed IS
    Pediatr Neurol; 2014 Aug; 51(2):284-5. PubMed ID: 25079580
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience.
    Perucca E
    CNS Drugs; 2002; 16(10):695-714. PubMed ID: 12269862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic encephalopathy precipitated by sodium valproate therapy.
    Subhash HS; Heddle RJ; Schultz DW; Ring J; Thompson CH
    Med J Aust; 2008 May; 188(9):549. PubMed ID: 18459937
    [No Abstract]   [Full Text] [Related]  

  • 34. Sodium valproate induced tremor in a patient with epilepsy and Down's syndrome.
    Siniscalchi A; Gallelli L; Loizzo S; Tiziana A; Russo E; De Sarro G
    Curr Drug Saf; 2013 Feb; 8(1):69-71. PubMed ID: 23656451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse drug reactions associated with six commonly used antiepileptic drugs in southern China from 2003 to 2015.
    Du Y; Lin J; Shen J; Ding S; Ye M; Wang L; Wang Y; Wang X; Xia N; Zheng R; Chen H; Xu H
    BMC Pharmacol Toxicol; 2019 Jan; 20(1):7. PubMed ID: 30642405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute childhood pancreatitis caused by valproate].
    Jakobović J; Butković D; Popović L; Skarić I; Mikecin L
    Lijec Vjesn; 2009; 131 Suppl 3():8-10. PubMed ID: 23120843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sleep Architecture in Valproate-Induced Nocturnal Enuresis in Primary School and Preschool Children.
    Esmael A; Elsherief M; Abdelsalam M; Bendary L; Egila H
    J Child Neurol; 2020 Dec; 35(14):975-982. PubMed ID: 32762394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carnitine deficiency associated with anticonvulsant therapy.
    Rodriguez-Segade S; de la Peña CA; Tutor JC; Paz JM; Fernandez MP; Rozas I; Del Río R
    Clin Chim Acta; 1989 May; 181(2):175-81. PubMed ID: 2500272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Valproate-induced hyperammonemic encephalopathy in a neonate: treatment with carglumic acid].
    Fernández Colomer B; Rekarte García S; García López JE; Pérez González C; Montes Granda M; Coto Cotallo GD
    An Pediatr (Barc); 2014 Oct; 81(4):251-5. PubMed ID: 24315420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An effective assessment of valproate sodium-induced hepatotoxicity with UPLC-MS and (1)HNMR-based metabonomics approach.
    Huo T; Chen X; Lu X; Qu L; Liu Y; Cai S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():109-16. PubMed ID: 25168794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.